NIAID (National Institute of Allergy and Infectious Diseases)
Scientific/Medical
Scientific/Medical Group Awards
NIAID Accelerating COVID-19 Therapeutic Interventions and Vaccines Team
For outstanding efforts to develop and implement the ACTIV-2 trial (Outpatient Monoclonal Antibodies and Other Therapies).